CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biofermin Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biofermin Pharmaceutical Co Ltd
5-5, Samban-cho, Nagata-ku
Phone: +81 783322890p:+81 783322890 KOBE-SHI, HYG  650-0021  Japan Fax: +81 783327227f:+81 783327227
This company was Merged or Acquired on 3/12/2008.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20213/31/2021Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board KenUehara 6/28/2017 6/28/2017
President, Representative Director HideyukiWaki 75 6/27/2018 6/26/2008
Managing Executive Officer, Director ToshimichiKunori
6 additional Officers and Directors records available in full report.

Business Names
Business Name
4517
Biofermin Pharmaceutical Co., Ltd.

General Information
Number of Employees: 236 (As of 3/31/2021)
Outstanding Shares: 11,961,275 (As of 3/31/2021)
Shareholders: 2,886
Stock Exchange: TYO
Fax Number: +81 783327227


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, November 5, 2024